Lionco Pharm Grp Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.32%

Lionco Pharm Grp Co Ltd (603669) has an Asset Resilience Ratio of 1.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥14.81 Million

≈ $2.17 Million USD Cash + Short-term Investments

Total Assets

CN¥1.12 Billion

≈ $164.14 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Lionco Pharm Grp Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Lionco Pharm Grp Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Lionco Pharm Grp Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lionco Pharm Grp Co Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥14.81 Million	1.32%
Total Liquid Assets	CN¥14.81 Million	1.32%

Asset Resilience Insights

Limited Liquidity: Lionco Pharm Grp Co Ltd maintains only 1.32% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Lionco Pharm Grp Co Ltd Industry Peers by Asset Resilience Ratio

Compare Lionco Pharm Grp Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Lionco Pharm Grp Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Lionco Pharm Grp Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.20%	CN¥13.32 Million ≈ $1.95 Million	CN¥1.11 Billion ≈ $161.96 Million	-1.28pp
2024-12-31	2.49%	CN¥31.22 Million ≈ $4.57 Million	CN¥1.26 Billion ≈ $183.69 Million	-21.56pp
2023-12-31	24.04%	CN¥390.59 Million ≈ $57.16 Million	CN¥1.62 Billion ≈ $237.72 Million	+3.05pp
2022-12-31	20.99%	CN¥389.51 Million ≈ $57.00 Million	CN¥1.86 Billion ≈ $271.51 Million	-2.04pp
2021-12-31	23.03%	CN¥579.13 Million ≈ $84.74 Million	CN¥2.51 Billion ≈ $367.93 Million	+16.41pp
2020-12-31	6.63%	CN¥180.00 Million ≈ $26.34 Million	CN¥2.72 Billion ≈ $397.47 Million	-11.97pp
2019-12-31	18.59%	CN¥355.78 Million ≈ $52.06 Million	CN¥1.91 Billion ≈ $280.00 Million	+2.88pp
2018-12-31	15.72%	CN¥325.00 Million ≈ $47.56 Million	CN¥2.07 Billion ≈ $302.60 Million	-14.56pp
2017-12-31	30.27%	CN¥500.00 Million ≈ $73.17 Million	CN¥1.65 Billion ≈ $241.69 Million	-6.93pp
2016-12-31	37.20%	CN¥500.00 Million ≈ $73.17 Million	CN¥1.34 Billion ≈ $196.67 Million	-7.46pp
2015-12-31	44.66%	CN¥600.00 Million ≈ $87.80 Million	CN¥1.34 Billion ≈ $196.60 Million	--

pp = percentage points

About Lionco Pharm Grp Co Ltd

SHG:603669 China Drug Manufacturers - Specialty & Generic

Market Cap

$561.83 Million

CN¥3.84 Billion CNY

Market Cap Rank

#11448 Global

#3174 in China

Share Price

CN¥5.39

Change (1 day)

+6.94%

52-Week Range

CN¥4.05 - CN¥8.11

All Time High

CN¥12.67